GT
DH icon

Glenmede Trust’s Definitive Healthcare DH Stock Holding History

Glenmede Trust’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$70.9K Buy
24,538
+1,548
+7% +$6.28K ﹤0.01% 1299
2024
Q4 		$94.5K Buy
22,990
+4,567
+25% +$20K ﹤0.01% 1303
2024
Q3 		$82.3K Buy
18,423
+5,362
+41% +$25.2K ﹤0.01% 1298
2024
Q2 		$71.3K Sell
13,061
-15,753
-55% -$99.2K ﹤0.01% 1267
2024
Q1 		$233K Buy
28,814
+4,506
+19% +$39.9K ﹤0.01% 1132
2023
Q4 		$242K Buy
24,308
+2,055
+9% +$16.1K ﹤0.01% 1094
2023
Q3 		$178K Buy
22,253
+1,151
+5% +$11.6K ﹤0.01% 1109
2023
Q2 		$218K Hold
21,102
– – ﹤0.01% 1076
2023
Q1 		$218K Buy
21,102
+7,265
+53% +$85.5K ﹤0.01% 1081
2022
Q4 		$152K Buy
13,837
+17
+0.1% +$219 ﹤0.01% 1120
2022
Q3 		$214K Buy
13,820
+155
+1% +$3.41K ﹤0.01% 1072
2022
Q2 		$313K Sell
13,665
-1,545
-10% -$33K ﹤0.01% 988
2022
Q1 		$374K Buy
+15,210
New +$343K ﹤0.01% 982

Other funds holding DH

AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenmede Trust's DH Position: Q1 2025 in Review

Glenmede Trust increased its Definitive Healthcare (DH) stake by 6.7% in Q1 2025, buying an estimated $6.28K and bringing the position to 24,538 shares worth $70.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

Glenmede Trust first reported a position in DH in Q1 2022 and has held it in 13 quarters since. The position peaked at $374K in Q1 2022. 136 funds tracked by Wall St. Rank hold DH as of Q1 2025.

  • Glenmede Trust held 24,538 shares of Definitive Healthcare worth $70.9K as of Q1 2025.
  • Glenmede Trust bought 1,548 Definitive Healthcare shares in Q1 2025, an estimated $6.28K.
  • Definitive Healthcare made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2025, its #1299 holding.
  • Glenmede Trust first reported a position in Definitive Healthcare in Q1 2022 and has held it in 13 quarters since.
  • Glenmede Trust's Definitive Healthcare position peaked at $374K in Q1 2022.
  • 136 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2025.

Based on Glenmede Trust's 13F filing for Q1 2025, filed 15 May 2025.